Century Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 15 | Q4 16 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | |
| 93.5% | 99.5% | – | – | – | – | – | – | – | – | 2,003.4% | 119.5% | 124.7% | 649.3% | 126.2% | 2,433.3% | 15,397.3% | 8,319.4% | 377.3% | 449.0% | 416.8% | 79.5% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | -549.3% | -26.2% | 100.0% | -15,297.3% | -8,219.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | |
| 1.2% | 1.9% | – | – | – | – | – | – | – | – | 2,003.4% | 1,754.6% | 1,164.5% | 4,910.7% | 1,447.6% | 22,956.6% | 18,100.0% | 8,692.5% | 2,739.3% | 3,530.5% | 3,442.2% | 703.9% | 24.3% | – | – | – | – | – | – | |
| 11.4% | 17.3% | – | – | – | – | – | – | – | – | 689.8% | 591.2% | 362.6% | 1,582.0% | 517.6% | 8,312.1% | 6,071.6% | 3,204.9% | 1,022.6% | 1,077.3% | 1,055.9% | 185.8% | 7.7% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 3,638.4% | 2,345.8% | 1,527.1% | 5,843.4% | 1,839.0% | 35,531.3% | 8,774.3% | 8,109.7% | 3,761.9% | 4,607.8% | 4,498.1% | 993.5% | 32.1% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -3,538.4% | -2,245.8% | -1,427.1% | -6,392.7% | -1,865.2% | -35,431.3% | -24,071.6% | -16,329.1% | -3,661.9% | -4,507.8% | -4,398.1% | -893.5% | 67.9% | – | – | – | – | – | – | |
| 2.5% | 6.2% | – | – | – | – | – | – | – | – | 29.7% | 23.6% | 16.8% | 79.3% | 23.5% | 137.4% | 0.0% | 403.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -3,544.1% | -2,218.5% | -1,381.5% | -6,074.9% | -1,747.4% | -32,667.7% | -21,708.1% | -15,025.0% | -3,282.0% | -4,044.7% | -3,948.7% | -821.9% | 70.1% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 1.5% | 1.3% | 1.1% | 6.1% | 70.2% | 959.6% | 400.0% | -324.3% | 0.1% | 2.9% | -1.0% | 42.6% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -3,545.7% | -2,219.8% | -1,382.6% | -6,081.0% | -1,817.7% | -33,627.3% | -22,108.1% | -14,700.7% | -3,282.1% | -4,047.6% | -3,947.7% | -864.4% | 70.1% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -3,412.0% | -2,080.8% | -1,243.4% | -5,346.3% | -1,597.8% | -29,263.6% | -19,105.4% | -10,098.9% | -2,904.7% | -3,595.7% | -3,531.7% | -742.4% | 73.1% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.